» » FDA approves expanded CV indication for Victoza

FDA approves expanded CV indication for Victoza

Health
No comments yet
  1. FDA approves expanded CV indication for Victoza  Healio
  2. Liraglutide Gains New Indication for Reducing CV Event Risk  AJMC.com Managed Markets Network
  3. FDA Approves Liraglutide for Cardiovascular Risk  MD Magazine (registration) (blog)Full coverage

posted from Health - Google News
Thank you for reading the FDA approves expanded CV indication for Victoza on Syria News Kit If you want to spread this News please include links as Source, and if this News useful please bookmark this page in your web browser, by pressing Ctrl + D on your keyboard button, Or click the share button to place it on your profile.

Latest news:

Jamal | Jamaluddin | Mas Jamal | Masterbama

Note: Only a member of this blog may post a comment.